Theme hub · 227 companies
Rare disease stocks
Daily analysis · Oct 27, 2026
Today's data shows 82 companies rose, 80 fell and one was unchanged, while median one-year changes by size band ranged from +31.5% for mid caps to -51.5% for micro caps.
- Vertex Pharmaceuticals Incorporated (VRTX34.SA): +5.1% one day move, mega cap
- Alnylam Pharmaceuticals, Inc. (A1LN34.SA): +9.1% one day move, large cap
- Oruka Therapeutics, Inc. (ORKA): +12.7% one day move, mid cap
Generated from today's data · Not investment advice
Heavily traded in Rare disease
Turnover over $10M/day75 of about 230 companies in this theme turn over more than $10M in a typical session. Largest market value first. Data as of Oct 27, 2026.
| Company | Turnover | 1Y return | Next report |
|---|---|---|---|
| VRTXVertex Pharmaceuticals Incorporated | $494.46M | +23.16% | Reports Nov 2, 2026 |
| ARGXargenx SE | $241.59M | +4.76% | — |
| ALNYAlnylam Pharmaceuticals, Inc. | $325.24M | −52.43% | Reports Oct 29, 2026 |
| ROIVRoivant Sciences Ltd. | $222.91M | +91.65% | Reports Nov 9, 2026 |
| INSMInsmed Incorporated | $194.09M | −43.10% | Reports Oct 29, 2026 |
| ASNDAscendis Pharma A/S | $159.80M | +20.63% | — |
| JAZZJazz Pharmaceuticals plc | $149.80M | +47.64% | Reports Nov 2, 2026 |
| BBIOBridgeBio Pharma, Inc. | $169.79M | +7.22% | Reports Oct 29, 2026 |
VRTX+23.16%$494.46MReports Nov 2, 2026Pre-earnings analysisARGX+4.76%$241.59MView analysisALNY−52.43%$325.24MReports Oct 29, 2026Pre-earnings analysisROIV+91.65%$222.91MReports Nov 9, 2026Pre-earnings analysisINSM−43.10%$194.09MReports Oct 29, 2026Pre-earnings analysisASND+20.63%$159.80MView analysisJAZZ+47.64%$149.80MReports Nov 2, 2026Pre-earnings analysisBBIO+7.22%$169.79MReports Oct 29, 2026Pre-earnings analysisTurnover over $10M/day
Turnover is the median value traded in one session, measured over the past 50 sessions. It describes trading activity in a stock and nothing about the company behind it.
Table
227 companies, largest market value first.
Data as of Oct 27, 2026 · updates nightly, Mon–Sat
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| VRTX | Vertex Pharmaceuticals Incorporated | $131.08B | Large cap | +23.16% |
| ARGX | argenx SE | $54.67B | Large cap | +4.76% |
| ALNY | Alnylam Pharmaceuticals, Inc. | $30.46B | Large cap | −52.43% |
| A1LN34.SA | Alnylam Pharmaceuticals, Inc. | $30.20B | Large cap | −52.23% |
| ROIV | Roivant Sciences Ltd. | $26.04B | Large cap | +91.65% |
| INSM | Insmed Incorporated | $20.38B | Large cap | −43.10% |
| ASND | Ascendis Pharma A/S | $16.13B | Large cap | +20.63% |
| JAZZ | Jazz Pharmaceuticals plc | $13.35B | Large cap | +47.64% |
| BBIO | BridgeBio Pharma, Inc. | $13.32B | Large cap | +7.22% |
| BMRN | BioMarin Pharmaceutical Inc. | $10.79B | Large cap | +5.85% |
| CORT | Corcept Therapeutics Incorporated | $9.42B | Mid cap | +20.07% |
| KYMR | Kymera Therapeutics, Inc. | $9.21B | Mid cap | +88.73% |
| PTGX | Protagonist Therapeutics, Inc. | $9.08B | Mid cap | +86.47% |
| CRNX | Crinetics Pharmaceuticals Inc | $9.01B | Mid cap | +91.59% |
| CYTK | Cytokinetics, Incorporated | $8.51B | Mid cap | +0.91% |
| ARWR | Arrowhead Pharmaceuticals, Inc. | $8.31B | Mid cap | +49.39% |
| 4151.T | Kyowa Kirin Co., Ltd. | $8.14B | Mid cap | +4.15% |
| IONS | Ionis Pharmaceuticals, Inc. | $7.22B | Mid cap | −40.51% |
| RYTM | Rhythm Pharmaceuticals, Inc. | $6.14B | Mid cap | −19.79% |
| IMVT | Immunovant, Inc. | $5.82B | Mid cap | +31.45% |
| MANE | Veradermics, Incorporated | $5.74B | Mid cap | +263.95% |
| KNSA | Kiniksa Pharmaceuticals International, plc | $5.61B | Mid cap | +79.75% |
| MIRM | Mirum Pharmaceuticals, Inc. | $5.41B | Mid cap | +16.33% |
| GRFS | Grifols, S.A. | $5.39B | Mid cap | −15.57% |
| ORKA | Oruka Therapeutics, Inc. | $5.31B | Mid cap | +226.10% |
| PTCT | PTC Therapeutics, Inc. | $5.10B | Mid cap | −8.96% |
| SRRK | Scholar Rock Holding Corporation | $5.08B | Mid cap | +36.75% |
| TVTX | Travere Therapeutics, Inc. | $4.65B | Mid cap | +67.85% |
| DNTH | Dianthus Therapeutics, Inc. | $4.34B | Mid cap | +136.66% |
| EWTX | Edgewise Therapeutics, Inc. | $4.25B | Mid cap | +144.35% |
| ARQT | Arcutis Biotherapeutics, Inc. | $4.00B | Mid cap | +61.97% |
| LQDA | Liquidia Corporation | $3.92B | Mid cap | +92.18% |
| IRON | Disc Medicine, Inc. | $3.45B | Mid cap | −13.37% |
| AMLX | Amylyx Pharmaceuticals, Inc. | $3.40B | Mid cap | +90.37% |
| DYN | Dyne Therapeutics, Inc. | $2.94B | Mid cap | −34.96% |
| VRDN | Viridian Therapeutics, Inc. | $2.64B | Mid cap | +3.55% |
| ADMA | ADMA Biologics, Inc. | $2.48B | Mid cap | −29.07% |
| CLDX | Celldex Therapeutics, Inc. | $2.32B | Mid cap | +7.78% |
| AUPH | Aurinia Pharmaceuticals Inc. | $2.27B | Mid cap | +38.65% |
| PHVS | Pharvaris N.V. | $2.21B | Mid cap | +38.21% |
| AGIO | Agios Pharmaceuticals, Inc. | $2.20B | Mid cap | −14.46% |
| VERA | Vera Therapeutics, Inc. | $2.02B | Mid cap | −6.94% |
| BCRX | BioCryst Pharmaceuticals, Inc. | $2.01B | Mid cap | +7.80% |
| SEPN | Septerna, Inc. | $1.89B | Small cap | +82.94% |
| XERS | Xeris Biopharma Holdings, Inc. | $1.86B | Small cap | +9.67% |
| MLYS | Mineralys Therapeutics, Inc. | $1.81B | Small cap | −49.31% |
| PVLA | Palvella Therapeutics, Inc. | $1.80B | Small cap | +79.23% |
| TRVI | Trevi Therapeutics, Inc. | $1.78B | Small cap | +19.14% |
| ZBIO | Zenas BioPharma, Inc. | $1.78B | Small cap | −14.34% |
| NEU.AX | Neuren Pharmaceuticals Limited | $1.75B | Small cap | −12.52% |
| MAZE | Maze Therapeutics, Inc. | $1.73B | Small cap | +0.23% |
| COAG | Hemab Therapeutics Holdings, Inc. | $1.68B | Small cap | +5.94% |
| ANIP | ANI Pharmaceuticals, Inc. | $1.67B | Small cap | −21.82% |
| STOK | Stoke Therapeutics, Inc. | $1.64B | Small cap | −22.85% |
| FBRX | Forte Biosciences Inc | $1.63B | Small cap | +492.23% |
| RARE | Ultragenyx Pharmaceutical Inc. | $1.59B | Small cap | −54.46% |
| TRAX | First Tracks Biotherapeutics, Inc. | $1.55B | Small cap | +128.84% |
| 009420.KS | Hanall Biopharma Co., Ltd. | $1.48B | Small cap | +15.52% |
| 4516.T | Nippon Shinyaku Co., Ltd. | $1.46B | Small cap | +4.08% |
| ANAB | AnaptysBio, Inc. | $1.46B | Small cap | +102.20% |
| KALV | KalVista Pharmaceuticals Inc | $1.44B | Small cap | +140.43% |
| ETON | Eton Pharmaceuticals, Inc. | $1.43B | Small cap | +171.48% |
| TYRA | Tyra Biosciences, Inc. | $1.40B | Small cap | +37.60% |
| NKTR | Nektar Therapeutics | $1.28B | Small cap | −40.15% |
| SLN | Silence Therapeutics plc | $1.23B | Small cap | +177.03% |
| PYC.AX | PYC Therapeutics Limited | $1.21B | Small cap | +43.85% |
| AVLN | Avalyn Pharma Inc. | $1.20B | Small cap | −7.97% |
| OMER | Omeros Corporation | $1.18B | Small cap | +111.28% |
| 006280.KS | GC Biopharma Corp. | $1.14B | Small cap | +0.62% |
| MLTX | MoonLake Immunotherapeutics | $1.01B | Small cap | +17.28% |
| JBIO | Jade Biosciences, Inc. | $922.16M | Small cap | +42.30% |
| SVRA | Savara Inc. | $864.79M | Small cap | +3.20% |
| PHAR | Pharming Group N.V. | $842.26M | Small cap | −10.73% |
| ANNX | Annexon, Inc. | $701.44M | Small cap | +4.52% |
| DSGN | Design Therapeutics, Inc. | $647.09M | Small cap | +48.35% |
| GYRE | Gyre Therapeutics, Inc. | $643.62M | Small cap | −24.31% |
| WVE | Wave Life Sciences, Inc. | $632.52M | Small cap | −57.87% |
| CRMD | CorMedix Inc. | $618.88M | Small cap | −28.14% |
| DBVT | DBV Technologies S.A. | $612.77M | Small cap | −37.59% |
| ZVRA | Zevra Therapeutics, Inc. | $582.55M | Small cap | −13.99% |
| IRWD | Ironwood Pharmaceuticals, Inc. | $578.34M | Small cap | +114.72% |
| 005257.KS | GC Corp. | $565.94M | Small cap | −33.38% |
| STTK | Shattuck Labs, Inc. | $550.99M | Small cap | +168.93% |
| VALN | Valneva SE | $512.99M | Small cap | −41.58% |
| CLYM | Climb Bio, Inc. | $506.01M | Small cap | +319.52% |
| AQST | Aquestive Therapeutics, Inc. | $502.05M | Small cap | −43.29% |
| KMDA | Kamada Ltd. | $458.22M | Small cap | +16.37% |
| AGMB | AgomAb Therapeutics NV | $422.06M | Small cap | −41.50% |
| ASMB | Assembly Biosciences, Inc. | $400.49M | Small cap | −33.99% |
| 4552.T | JCR Pharmaceuticals Co., Ltd. | $400.36M | Small cap | −13.24% |
| TECX | Tectonic Therapeutic, Inc. | $390.01M | Small cap | +7.14% |
| SPRY | ARS Pharmaceuticals, Inc. | $389.83M | Small cap | −59.00% |
| RZLT | Rezolute, Inc. | $369.48M | Small cap | −59.58% |
| AVTX | Avalo Therapeutics, Inc. | $363.08M | Small cap | −62.37% |
| ZURA | Zura Bio Limited | $341.15M | Small cap | −9.41% |
| ENTA | Enanta Pharmaceuticals, Inc. | $339.02M | Small cap | +14.29% |
| AVIR | Atea Pharmaceuticals, Inc. | $333.65M | Small cap | +28.00% |
| XFOR | X4 Pharmaceuticals, Inc. | $322.23M | Small cap | −13.10% |
| TTRX | Turn Therapeutics Inc. | $322.20M | Small cap | +113.48% |
| FULC | Fulcrum Therapeutics, Inc. | $278.03M | Small cap | −62.28% |
| QTTB | Q32 Bio Inc. | $251.55M | Small cap | +201.79% |
| CUV.AX | Clinuvel Pharmaceuticals Limited | $248.43M | Small cap | −38.51% |
| LRMR | Larimar Therapeutics, Inc. | $244.12M | Small cap | −48.39% |
| IFRX | InflaRx N.V. | $232.10M | Small cap | −5.12% |
| SLGL | Sol-Gel Technologies Ltd. | $227.38M | Small cap | +74.91% |
| KROS | Keros Therapeutics, Inc. | $224.64M | Small cap | −24.62% |
| SIGA | SIGA Technologies, Inc. | $224.17M | Small cap | −57.69% |
| IKT | Inhibikase Therapeutics, Inc. | $212.09M | Small cap | −2.56% |
| CAMP | CAMP4 THERAPEUTICS CORPORATION | $201.44M | Small cap | −17.69% |
| PLX | Protalix BioTherapeutics, Inc. | $199.82M | Small cap | +4.20% |
| 0AB6.L | Hyloris Pharmaceuticals SA | $185.32M | Small cap | −28.56% |
| TRDA | Entrada Therapeutics, Inc. | $184.95M | Small cap | −35.02% |
| PRQR | ProQR Therapeutics N.V. | $182.04M | Small cap | −56.64% |
| IVVD | Invivyd, Inc. | $180.81M | Small cap | −72.60% |
| ELDN | Eledon Pharmaceuticals, Inc. | $179.59M | Small cap | −42.30% |
| AKBA | Akebia Therapeutics, Inc. | $178.40M | Small cap | −79.69% |
| PEPG | PepGen Inc. | $172.46M | Small cap | −54.14% |
| SION | Sionna Therapeutics, Inc. | $166.83M | Small cap | −90.37% |
| MDWD | MediWound Ltd. | $155.76M | Small cap | −34.41% |
| UPB | Upstream Bio, Inc. | $150.62M | Small cap | −88.34% |
| RNA | Atrium Therapeutics, Inc. | $140.27M | Small cap | −45.42% |
| ANTX | AN2 Therapeutics, Inc. | $133.96M | Small cap | +168.89% |
| SPRB | Spruce Biosciences, Inc. | $129.76M | Small cap | −64.24% |
| ARMP | Armata Pharmaceuticals, Inc. | $128.28M | Small cap | −34.54% |
| PAR.AX | Paradigm Biopharmaceuticals Limited | $107.73M | Small cap | −44.94% |
| PYPD | PolyPid Ltd. | $106.64M | Small cap | +46.54% |
| UNCY | Unicycive Therapeutics, Inc. | $98.07M | Micro cap | −31.68% |
| INO | Inovio Pharmaceuticals, Inc. | $92.76M | Micro cap | −65.07% |
| RLYB | Rallybio Corporation | $88.40M | Micro cap | +233.00% |
| PLYX | Polaryx Therapeutics, Inc. | $86.16M | Micro cap | −94.80% |
| DXB.AX | Dimerix Limited | $84.29M | Micro cap | −60.78% |
| MIST | Milestone Pharmaceuticals Inc. | $80.23M | Micro cap | −66.26% |
| EQ | Equillium, Inc. | $79.26M | Micro cap | −8.76% |
| TELO | Telomir Pharmaceuticals, Inc. | $73.51M | Micro cap | −36.40% |
| FBIOP | Fortress Biotech, Inc. | $71.45M | Micro cap | +130.77% |
| RCE.AX | Recce Pharmaceuticals Ltd | $69.76M | Micro cap | −21.69% |
| RFL | Rafael Holdings, Inc. | $68.12M | Micro cap | −12.59% |
| CPIX | Cumberland Pharmaceuticals Inc. | $65.18M | Micro cap | +36.36% |
| ILA.AX | Island Pharmaceuticals Limited | $64.39M | Micro cap | −21.52% |
| TENX | Tenax Therapeutics, Inc. | $64.37M | Micro cap | −78.13% |
| FBIO | Fortress Biotech, Inc. | $62.37M | Micro cap | −27.24% |
| SPRO | Spero Therapeutics, Inc. | $62.31M | Micro cap | −53.28% |
| PTHS | Pelthos Therapeutics Inc. | $58.19M | Micro cap | −52.50% |
| 4599.T | StemRIM | $56.89M | Micro cap | −48.61% |
| GOSS | Gossamer Bio, Inc. | $55.96M | Micro cap | +282.85% |
| RNTX | Rein Therapeutics Inc. | $50.31M | Micro cap | −56.80% |
| 520A.T | J-Pharma Co., Ltd. | $49.31M | Micro cap | −41.86% |
| IMA | ImageneBio, Inc. | $45.97M | Micro cap | −51.50% |
| NSRX | Nasus Pharma Ltd. | $40.88M | Micro cap | −56.10% |
| GRCE | Grace Therapeutics, Inc. | $38.08M | Micro cap | −42.54% |
| SCYX | SCYNEXIS, Inc. | $37.91M | Micro cap | +405.98% |
| EDSA | Edesa Biotech, Inc. | $34.99M | Micro cap | −1.52% |
| NNVC | NanoViricides, Inc. | $34.73M | Micro cap | −15.53% |
| QNCX | Quince Therapeutics Inc | $32.27M | Micro cap | +84.80% |
| 4884.T | Kringle Pharma, Inc. | $30.61M | Micro cap | +36.08% |
| BRNS | Barinthus Biotherapeutics PLC | $30.23M | Micro cap | −41.73% |
| BOT.AX | Botanix Pharmaceuticals Limited | $25.20M | Micro cap | −90.71% |
| AARD | Aardvark Therapeutics, Inc. | $23.64M | Micro cap | −90.76% |
| 4591.T | Ribomic Inc. | $23.33M | Micro cap | −29.03% |
| MCRB | Seres Therapeutics, Inc. | $19.89M | Micro cap | −88.47% |
| QNRX | Quoin Pharmaceuticals, Ltd. | $19.26M | Micro cap | −69.62% |
| VYNE | VYNE Therapeutics Inc | $19.07M | Micro cap | +7811.36% |
| COCP | Cocrystal Pharma, Inc. | $18.72M | Micro cap | −20.98% |
| JSPR | Jasper Therapeutics, Inc. | $16.82M | Micro cap | −78.31% |
| ATYR | aTyr Pharma, Inc. | $15.05M | Micro cap | −84.23% |
| 4881.T | FunPep Company Limited | $13.83M | Micro cap | −56.57% |
| KTTA | Pasithea Therapeutics Corp. | $13.36M | Micro cap | −43.52% |
| HIND | Vyome Holdings, Inc. | $12.56M | Micro cap | −69.02% |
| TVRD | Tvardi Therapeutics, Inc. | $11.23M | Micro cap | −82.71% |
| AZTR | Azitra, Inc. | $9.27M | Micro cap | +180.22% |
| IMC.AX | Immuron Limited | $9.06M | Micro cap | −56.52% |
| CALC | CalciMedica, Inc. | $8.88M | Micro cap | −57.10% |
| INM | InMed Pharmaceuticals Inc. | $8.74M | Micro cap | −22.06% |
| SNGX | Soligenix, Inc. | $7.94M | Micro cap | −77.56% |
| IMRN | Immuron Limited | $7.43M | Micro cap | −58.18% |
| CMMB | Chemomab Therapeutics Ltd. | $7.33M | Micro cap | −67.21% |
| XCUR | Exicure, Inc. | $7.14M | Micro cap | −76.71% |
| PULM | Pulmatrix, Inc. | $5.26M | Micro cap | −70.79% |
| GLMD | Galmed Pharmaceuticals Ltd. | $4.95M | Micro cap | +162.32% |
| JAGX | Jaguar Health, Inc. | $3.97M | Micro cap | −96.70% |
| VBS.AX | Vectus Biosystems Limited | $3.93M | Micro cap | −35.71% |
| BIT.AX | Biotron Limited | $3.91M | Micro cap | −33.33% |
| GRI | GRI Bio, Inc. | $3.28M | Micro cap | −97.35% |
| SXTP | 60 Degrees Pharmaceuticals, Inc. | $3.05M | Micro cap | −85.34% |
| CVKD | Cadrenal Therapeutics, Inc. | $2.82M | Micro cap | −93.05% |
| ANR.AX | Anatara Lifesciences Ltd | $2.00M | Micro cap | −35.71% |
| XRTX | XORTX Therapeutics Inc. | $1.93M | Micro cap | −68.02% |
| VBIO | Valion Bio, Inc. | $1.76M | Micro cap | −70.00% |
| MTNB | Matinas BioPharma Holdings, Inc. | $1.63M | Micro cap | +8.36% |
| 0R55.L | BioSenic S.A. | $26.40K | Micro cap | −20.00% |
| 0A8U.L | Synlogic, Inc. | — | — | −38.22% |
| 0A9G.L | Mereo BioPharma Group plc | — | — | −86.42% |
| 1AE.DE | argenx SE | — | — | +0.19% |
| A1RG34.SA | argenx SE | — | Mega cap | −9.29% |
| A2RR34.SA | Arrowhead Pharmaceuticals, Inc. | — | Mid cap | +36.34% |
| ABNX.PA | ABIONYX Pharma SA | — | Small cap | −53.55% |
| ABVX.PA | ABIVAX Société Anonyme | — | Mid cap | −1.08% |
| ALBPS.PA | Biophytis S.A. | — | — | −71.04% |
| ALDVI.PA | Advicenne S.A. | — | — | −61.72% |
| ALNEV.PA | Neovacs S.A. | — | — | −31.82% |
| ALTHX.PA | THX Pharma Société Anonyme | — | — | +27.91% |
| ANNX.ST | Annexin Pharmaceuticals AB (publ) | — | Small cap | −68.45% |
| APLI.TO | Appili Therapeutics Inc. | — | — | −66.67% |
| APTA.ST | Aptahem AB (publ) | — | — | −79.45% |
| B1MR34.SA | BioMarin Pharmaceutical Inc. | — | Large cap | −0.89% |
| BIOSGN.ST | Biosergen AB (publ) | — | — | −99.01% |
| BIOV.SW | BioVersys AG | — | — | +2.90% |
| BPBS.PA | BIOPHYTIS BSA | — | — | 0.00% |
| BSLN.SW | Basilea Pharmaceutica AG | — | — | +39.09% |
| CAMX.ST | Camurus AB (publ) | — | Large cap | −2.63% |
| CESSA.CO | Cessatech A/S | — | — | −49.04% |
| CRDL.TO | Cardiol Therapeutics Inc. | — | Small cap | −5.88% |
| CRNO-B.ST | Cereno Scientific AB (publ) | — | Small cap | −57.04% |
| CURN.SW | Curatis Holding AG | — | — | +36.80% |
| DBV.PA | DBV Technologies S.A. | — | Small cap | −41.82% |
| EPRX.TO | Eupraxia Pharmaceuticals Inc. | — | Small cap | +26.16% |
| GNFT.PA | Genfit S.A. | — | Small cap | +128.93% |
| IMM.L | ImmuPharma plc | — | — | −65.96% |
| MDP.TO | Medexus Pharmaceuticals Inc. | — | Small cap | +68.51% |
| MSCL.TO | Satellos Bioscience Inc. | — | Small cap | +12.68% |
| PHGN.DE | Pharming Group N.V. | — | — | −31.40% |
| PHR.WA | Pharmena S.A. | — | — | −12.57% |
| REC.MI | Recordati Industria Chimica e Farmaceutica S.p.A. | — | Large cap | +5.26% |
| RVX.TO | Resverlogix Corp. | — | — | −20.00% |
| SANN.SW | Santhera Pharmaceuticals Holding AG | — | — | +37.07% |
| STX.L | Shield Therapeutics plc | — | Small cap | −30.07% |
| VRTX34.SA | Vertex Pharmaceuticals Incorporated | — | Mega cap | −84.64% |
Covers ~23,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Price and the 52-week distance are in the currency the stock trades in; only market values are converted.
We cover 227 companies grouped under the Rare disease theme. The median market value in the group is $340.09M. Among the 164 with a price from the latest session, the median move over the past trading day is +0.06%. 25% of the 214 with a 200-day average trade above it. Price change over the past year runs from −70.9% to +112.2% across the middle 80 percent of the group, with a median of −14.5%. Across the group, 1 company currently carries a tier A volume signal.
Other lists in this group
Rare diseaseAdvanced packagingAerospaceAgriculture and agribusinessAI applicationsAI chipsAI datacenter infrastructureAirlinesAlcoholic beveragesAlternative asset managersAluminumApparel and footwearAR VR mixed realityAsset managementAuto partsAutomotive OEMsAutonomous driving softwareBeauty and personal careBiofuelsBitcoin miningBlockchain platformsBrokerage and exchangesBuilding productsCannabisAll stocks
The other 156 themes
Carbon captureCarbon creditsCasual diningCell therapyCell tower REITCement and aggregatesCoal miningCobaltCommercial office REITCommodity chemicalsComputer visionConstruction and engineeringConsumer financeContainers and packagingContract research CDMOCopper miningCredit rating and dataCruise linesCryptocurrency and digital assetsCybersecurityData platformsDatacenter coolingDatacenter powerDatacenter REITDefense electronicsDefense prime contractorsDental careDeveloper toolsDiabetes careDiagnosticsDiamonds and gemstonesDiscount retailDrones and UAVEcommerce marketplacesEcommerce platformsEdge computingEdtechElectrical equipmentEnergy storageEsportsEV batteriesEV chargingEV makersFast food and quick serviceFintech softwareGambling and casinosGaming softwareGene therapyGenerative AIGeneric drugsGeothermalGLP 1 and obesityGold miningGPU cloud computeGraphiteGrocery and supermarketsHealth insuranceHealthcare REITHealthtech softwareHome improvementHomebuildersHospitals and providersHotel REITHotels and hospitalityHousehold productsHR techHVAC and controlsHydroelectricHydrogen economyIndustrial automationIndustrial gasesIndustrial machineryIndustrial REITInsurance brokersInvestment bankingIoT platformsIron oreLife insuranceLife science toolsLithium miningLogistics and 3PLLong term careLumber and forestryLuxury goodsMarine shippingMartech adtechMedical devicesMemory storage semisMissiles and munitionsMoney center banksMortgage financeMortgage REITmRNA platformsNatural gas utilitiesNeobanks and digital banksNeuroscienceNickelNon alcoholic beveragesNuclear powerOil and gas explorationOil and gas midstreamOil and gas refiningOil and gas servicesOncologyOnline travelPackaged foodsPayment processingPet carePharmaceuticals large capPotash fertilizerProperty casualty insurancePsychedelic therapeuticsQuantum computingRail transportRare earthsReal estate servicesRegional banksRegulated electric utilitiesReinsuranceRenewable energy developersResidential REITRetail REITRide hailing and deliveryRobotics hardwareSaaSSelf storage REITSemiconductor designSemiconductor equipmentSemiconductor manufacturingShipbuildingSilver miningSocial mediaSolarSpace launch and satellitesSpecialty chemicalsSpecialty financeSpecialty REITSpecialty retailSpeech and audio AISteelStreaming mediaSupply chain softwareSurgical roboticsTelecom equipmentTelecom infrastructureTelemedicineTobacco and nicotineTravel and leisureTrucking and LTLUranium miningVeterinary and animal healthVision and ophthalmologyWaste managementWater utilities and treatmentWealth managementWind